Selective Antineoplastic Potential of Fractionated Caribbean Native
Ganoderma martinicense
Ganoderma multiplicatum
MCF-10A
SUM149PT
cytotoxicity
fractions
natural product
triple-negative breast cancer
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
01 Jul 2024
01 Jul 2024
Historique:
received:
07
06
2024
revised:
24
06
2024
accepted:
25
06
2024
medline:
27
7
2024
pubmed:
27
7
2024
entrez:
27
7
2024
Statut:
epublish
Résumé
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor type 2 expression. It is known for its high malignancy, invasiveness, and propensity for metastasis, resulting in a poor prognosis due to the absence of beneficial therapeutic targets. Natural products derived from mushrooms have gained significant attention in neoplastic therapy due to their potential medicinal properties. The therapeutic potential of
Identifiants
pubmed: 39065715
pii: ph17070864
doi: 10.3390/ph17070864
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIH HHS
ID : R16GM145488
Pays : United States
Organisme : NIH HHS
ID : SC3GM111171
Pays : United States
Organisme : NIH HHS
ID : U54GM133807
Pays : United States
Organisme : NIH HHS
ID : S21MD001830
Pays : United States
Organisme : U.S. Department of Agriculture/National Institute of Food and Agriculture/Small Business Innovation Research
ID : 2022-33530-37064
Organisme : Puerto Rico Science, Technology & Research Trust Therapeutic Accelerator Program
ID : 2022-00121
Organisme : Susan G. Komen ASPIRE
ID : ASP231046822
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.